Financhill
Sell
16

IMVT Quote, Financials, Valuation and Earnings

Last price:
$14.01
Seasonality move :
-4.54%
Day range:
$13.36 - $14.76
52-week range:
$12.72 - $34.47
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
6.89x
Volume:
940.6K
Avg. volume:
1.9M
1-year change:
-51.95%
Market cap:
$2.4B
Revenue:
--
EPS (TTM):
-$2.62

Earnings Data

Next earnings date for IMVT
May 29
2025
Most recent earnings per share
-$0.76
Missed by $0.01
(Feb 6/2025)
Consensus Estimate
-$0.75
(Feb 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

IMVT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 -- -- -- -$0.73 --
05/29/2025 Q1 -- -- -- -$0.72 --
02/06/2025 Q4 -- -- -$0.76 -$0.75 -$0.01
11/07/2024 Q3 -- -- -$0.74 -$0.61 -$0.13
08/06/2024 Q2 -- -- -$0.60 -$0.52 -$0.08
05/29/2024 Q1 -- -- -$0.52 -$0.43 -$0.09
02/12/2024 Q4 -- -- -$0.36 -$0.42 $0.06
11/09/2023 Q3 -- -- -$0.45 -$0.46 $0.01
08/10/2023 Q2 -- -- -$0.57 -$0.44 -$0.13
05/22/2023 Q1 -- -- -$0.46 -$0.41 -$0.05
02/03/2023 Q4 -- -- -$0.49 -$0.37 -$0.12
11/04/2022 Q3 -- -- -$0.41 -$0.36 -$0.05
08/05/2022 Q2 -- -- -$0.35 -$0.40 $0.05
06/08/2022 Q1 -- -- -$0.41 -$0.35 -$0.06
02/04/2022 Q4 -- -- -$0.36 -$0.31 -$0.05
11/05/2021 Q3 -- -- -$0.35 -$0.27 -$0.08
08/06/2021 Q2 -- -- -$0.31 -$0.32 $0.01
06/01/2021 Q1 -- -- -$0.28 -$0.34 $0.06
02/16/2021 Q4 -- -- -$0.32 -$0.25 -$0.07
11/12/2020 Q3 -- -- -$0.25 -$0.30 $0.05
08/12/2020 Q2 -- -- -$0.38 -$0.32 -$0.06
06/29/2020 Q1 -- -- -$0.38 -$0.28 -$0.10
02/14/2020 Q4 -- -- -$0.28 -$0.26 -$0.03
09/30/2019 Q3 -- -- $0.01 -- --
08/12/2019 Q2 -- -- $0.01 -- --
06/12/2019 Q1 -- -- -$0.00 -- --

Immunovant Earnings Questions

  • How Much did Immunovant Generate in Revenue Last Quarter?

    Immunovant reported -- worth of top line sales in its most recent quarter.

  • Did Immunovant Beat Earnings Last Quarter?

    Immunovant announced earnings per share of -$0.76 which represents a miss of analyst forecast a -$0.75 per share.

  • Is Immunovant Profitable?

    Immunovant reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Immunovant EPS Next Year?

    Immunovant's earnings are forecast to decrease from -$1.88 per share to -$2.87 per share next year representing a decrease of -56.07%.

  • When is Immunovant's Earnings Date?

    Immunovant's next earnings date is May 29, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Spotify a Millionaire-Maker Stock?
Is Spotify a Millionaire-Maker Stock?

Spotify (NYSE:SPOT) may seem like an expensive proposition trading closer…

What Is a Millionaire-Maker Stock?
What Is a Millionaire-Maker Stock?

From time to time, investors will run across the term…

5 Investors to Follow Other Than Warren Buffett
5 Investors to Follow Other Than Warren Buffett

There is no doubt that Warren Buffett is one of…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Buy
99
DAVE alert for May 9

Dave [DAVE] is up 9.31% over the past day.

Buy
52
QDEL alert for May 9

QuidelOrtho [QDEL] is down 0.22% over the past day.

Buy
61
TPC alert for May 9

Tutor Perini [TPC] is up 9.61% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock